Alnylam Pharmaceuticals
ALNY
#618
Rank
โ‚น2.608 T
Marketcap
โ‚น20,152
Share price
-10.08%
Change (1 day)
59.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company